Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    New page revision v3.5.4 was published, replacing the prior v3.5.3. This marks a minor update to the page version, with no apparent changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-15T07:40:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s displayed release/revision version from v3.5.2 to v3.5.3 without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:35:59.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T21:52:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added revision: v3.4.3. Deleted revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:39.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the previous funding/operating status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T09:27:19.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.